RO Principles & Practice: Histology-Driven Management of Soft Tissue Sarcoma
This presentation is aimed at residents in advanced years of training and attending physicians seeking a practical update on the management of patients with soft tissue sarcoma.
Category
  • Sarcoma
  • RO Principles & Practice
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
RO Principles & Practice: Pediatric Medulloblastomas and Primitive Neuroectodermal Tumors
This presentation provides a review of workup, staging, and management of pediatric medulloblastomas and primitive neuroectodermal tumors (PNETs) including treatment planning considerations and future directions.
Category
  • Pediatric
  • RO Principles & Practice
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Certificate of Attendance
Cost $149.00
The Role of Radiotherapy in the Management of Non-Malignant Diseases of the Head and Neck
The role of radiotherapy in the management of benign diseases is ever expanding. Non-malignant entities of the head and neck are particularly complex and represent therapeutic challenges given the potential for treatment-associated morbidities.
Category
  • Head and Neck
  • Functional/Nonmalignant RT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Nasal Cavity and Paranasal Sinus Tumors: A Multi-Disciplinary Discussion
The management of patients with nasal cavity and paranasal sinus tumors is challenging and constantly evolving. It often requires true trimodality care involving radiation oncology, otolaryngology and medical oncology, along with a variety of different supportive services.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Evolution of Accreditation: How APEx has Evolved to Adopt New Indications
As complexity of radiation therapy increases, ensuring that health care institutions meet rigorous quality standards becomes paramount.
Category
  • Radiopharmaceutical Therapy
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Prevention and Management of RT-related Skin Toxicities
An estimated 90% of patients treated with radiotherapy for breast cancer will develop radiation-induced dermatitis. On the molecular level, radiation upregulates cytokine cascades and fibro-inflammatory pathways, leading to substantial fibrosis, the hallmark of chronic RT damage.
Category
  • Skin
  • Breast
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Imaging Biomarkers in Radiotherapy: Enhancing Precision and Personalization
This activity explores the evolving role of imaging biomarkers in radiotherapy, focusing on their capacity to improve target delineation, systemically predict and monitor treatment responses, and inform personalized clinical decision making on adaptive platforms.
Category
  • Adaptive RT
  • Physics
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Role of Radiation in Oligometastatic and Polymetastatic Disease
Radiation therapy continues to make significant strides in the management of early-stage and locally advanced solid tumor malignancies.
Category
  • SBRT
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Contouring for Pancreatic Cancer
Accurate target delineation is fundamental to the safe and effective delivery of radiation therapy for pancreatic cancer, particularly as dose-escalated approaches become increasingly adopted. This activity is designed to refine contouring skills for pancreatic cancer.
Category
  • Gastrointestinal
Format
  • Sessions onDemand
  • Contouring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Latest Developments in Management of High-Risk Prostate Cancer
There are many ongoing advances in the management of high risk and locally advanced prostate cancer, including concepts of systemic therapy intensification and de-escalation, dose escalation, and the use of biomarkers.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages